Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Insurance, Financial Strain, Family Function, and Psychosocial Wellbeing in Pediatric Patients and Parents with Hematologic Malignancies

Nadia Syed, Stacie Dusetzina, Tatsuki Koyama, Emma Schremp, Meredith Smalls, Debra L. Friedman

Blood (2024) 144 (Supplement 1): 2279.

https://doi.org/10.1182/blood-2024-207908

Published: 2024

Journal Articles

Performance of Positron Emission Tomography at Diagnosis and Response Assessment in Low and Intermediate-Risk Nodular Lymphocyte Predominant Hodgkin Lymphoma

Lianna J. Marks, Kathleen McCarten, Qinglin Pei, Yue Wu, Kara M. Kelly, Cindy Schwartz, Suzanne Wolden, Debra L. Friedman, Sharon M. Castellino, Burton Appel

Blood (2023) 142 (Supplement 1): 1699.

https://doi.org/10.1182/blood-2023-179465

Published: 2023

Journal Articles

A gene expression–based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma

Rebecca L. Johnston, Anja Mottok, Fong Chun Chan, Aixiang Jiang, Arjan Diepstra, Lydia Visser, Adèle Telenius, Randy D. Gascoyne, Debra L. Friedman, Cindy L. Schwartz, Kara M. Kelly, David W. Scott, Terzah M. Horton, Christian Steidl

Blood (2022) 139 (6): 889–893.

https://doi.org/10.1182/blood.2021011941

Published: 2022

Includes: Supplemental data

Journal Articles

The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity

Andrea C. Lo, Amy Liu, Qi Liu, Yutaka Yasui, Sharon M. Castellino, Kara M. Kelly, Alex F. Herrera, Jonathan W. Friedberg, Debra L. Friedman, Cindy L. Schwartz, Samuel Bergeron-Gravel, Hitesh Dama, Kenneth B. Roberts, Louis S. Constine, David Hodgson

Blood (2021) 138 (Supplement 1): 881.

https://doi.org/10.1182/blood-2021-147678

Published: 2021

Journal Articles

Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group

Lisa Giulino-Roth, Qinglin Pei, Allen Buxton, Rizvan Bush, Yue Wu, Suzanne L. Wolden, Louis S. Constine, Kara M. Kelly, Cindy L. Schwartz, Debra L. Friedman

Blood (2021) 137 (11): 1449–1456.

https://doi.org/10.1182/blood.2020007225

Published: 2021

Includes: Supplemental data

Journal Articles

Survival Varies By Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group

Justine M. Kahn, MDMSc, Kara M. Kelly, MD, Qinglin Pei, PhD, Yue Wu, MS, Debra L. Friedman, MD, Tara O. Henderson, MD MPH, David C. Hodgson, MD MPH, FRCPC, Joel A. Kaplan, DO, MPH, Frank G. Keller, MD, Smita Bhatia, MDMPH, Cindy L. Schwartz, MD, Sharon M. Castellino, MD MSc

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-138796

Published: 2020

Journal Articles

Pericardial effusion in Hodgkin lymphoma: a report from the Children’s Oncology Group AHOD0031 protocol

Lianna J. Marks, Kathleen M. McCarten, Qinglin Pei, Debra L. Friedman, Cindy L. Schwartz, Kara M. Kelly

Blood (2018) 132 (11): 1208–1211.

https://doi.org/10.1182/blood-2018-02-834465

Published: 2018

Journal Articles

Survival By Race/Ethnicity in Children and Adolescents with Hodgkin Lymphoma Treated on Cooperative Group Trials in the U.S. and Canada: A Pooled Analysis of Children's Oncology Group Trials

Justine M. Kahn, MD, Kara M. Kelly, MD, Qinglin Pei, PhD, Debra L. Friedman, MD, Frank Keller, MD, Rizvan Bush, MS, Smita Bhatia, MDMPH, Tara O. Henderson, MD MPH, Cindy L. Schwartz, MD, Sharon M. Castellino, MD MSc

Blood (2017) 130 (Supplement 1): 607.

https://doi.org/10.1182/blood.V130.Suppl_1.607.607

Published: 2017

Journal Articles

Intermediate-Risk Lymphocyte-Predominant Hodgkin Lymphoma: AHOD0031: A Report from the Children's Oncology Group

Lianna J. Marks, MD, Qinglin Pei, PhD, Allen Buxton, MS, Burton Appel, MD, Kara M. Kelly, MD, Cindy L. Schwartz, MD MPH, Debra L. Friedman, MD MS

Blood (2016) 128 (22): 1814.

https://doi.org/10.1182/blood.V128.22.1814.1814

Published: 2016

Journal Articles

Subsequent Malignant Neoplasms Among Children and Adolescents with Hodgkin Lymphoma Treated with Response-Adapted Therapy: A Report from the Children's Oncology Group Study AHOD0031

Lisa Giulino-Roth, MD, Qinglin Pei, PhD, Allen Buxton, MS, Suzanne Wolden, MD, Louis S. Constine, MD, Kara M. Kelly, MD, Cindy L. Schwartz, MD MPH, Debra L. Friedman, MD MS

Blood (2016) 128 (22): 924.

https://doi.org/10.1182/blood.V128.22.924.924

Published: 2016

Journal Articles

An Adjustable Markov Model to Project Life Expectancy (LE) for Early Stage Favorable Risk Hodgkin Lymphoma Patients Treated with Contemporary Therapy

Michael J. Kelly, MD MPH, MS, Susan K Parsons, MDMRP, David C. Hodgson, MD, Joshua T Cohen, PhD, Jennifer M Yeh, MD PhD, Jeremy S. Abramson, MD, Debra L. Friedman, MD MS, Tara O Henderson, MDMPH, Peter W Johnson, MD, Stephen G Pauker, MD, John M. Raemaekers, MD PhD, Jane N. Winter, MD, Kara M. Kelly, MD, Ralph M. Meyer, MD, Sharon M Castellino, MD, Andrew M. Evens, DO, MSc

Blood (2015) 126 (23): 2635.

https://doi.org/10.1182/blood.V126.23.2635.2635

Published: 2015

Journal Articles

Outcomes in Adolescents and Young Adults (AYA) with Hodgkin Lymphoma (HL) Treated on US Cooperative Group Protocols: An Adult Intergroup (E2496) and Children's Oncology Group (COG AHOD0031) Comparative Analysis

Blood (2015) 126 (23): 2636.

https://doi.org/10.1182/blood.V126.23.2636.2636

Published: 2015

Journal Articles

Prediction of Primary Treatment Outcome Using Gene Expression Profiling of Pre-Treatment Biopsies Obtained from Childhood and Adolescent Hodgkin Lymphoma Patients

Anja Mottok, MD, Rebecca Lea Johnston, Fong Chun Chan, MSc, David W Scott, MBChB, PhD, Debra L. Friedman, MD MS, Cindy Schwartz, MD, Kara M. Kelly, MD, Terzah M. Horton, MD PhD, Christian Steidl, MD

Blood (2015) 126 (23): 175.

https://doi.org/10.1182/blood.V126.23.175.175

Published: 2015

Journal Articles

18 f-FDG (FDG) PET Five-Point Visual and Quantitative SUV-Based Assessment and Prognosis in Pediatric Hodgkin Lymphoma (HL). A Preliminary Retrospective Analysis of Children's Oncology Group (COG) AHOD0031

Steve Y Cho, MD, Kathleen M McCarten, MD, Lu Chen, PhD, Debra L Friedman, MD, MS, Suzanne L Wolden, MD, Kathryn Karolczuk, Cindy L Schwartz, MD, MPH, Kara M Kelly, MD

Blood (2012) 120 (21): 1530.

https://doi.org/10.1182/blood.V120.21.1530.1530

Published: 2012

Journal Articles

The Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event Free Survival in Pediatric and Adolescent Hodgkin Lymphoma,

Cindy Schwartz, MD, MPH, Lu Chen, PhD, Louis Constine, MD, Suzanne Wolden, Frank G Keller, MD, Kara M Kelly, MD, Debra l Friedman, MD, MS

Blood (2011) 118 (21): 3649.

https://doi.org/10.1182/blood.V118.21.3649.3649

Published: 2011

Journal Articles

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

Debra l Friedman, MD, MS, Suzanne Wolden, Louis Constine, MD, Lu Chen, PhD, Kathleen M McCarten, MD, T. J Fitzgerald, Pedro De Alarcon, MD, Allen R. Chen, MD, PhD, MHS, Robert Hutchison, MD, Peter Ehrlich, Nathan L. Kobrinsky, MD, FRCP, Meghan Higman, Shirley Hogan, Lorna Roll, Tanya Trippett, Cindy Schwartz, MD

Blood (2010) 116 (21): 766.

https://doi.org/10.1182/blood.V116.21.766.766

Published: 2010

Journal Articles

Population-Based Analysis of Late Cardiovascular Morbidity and Hospitalizations After Hematopoietic Cell Transplantation.

Eric J Chow, MD, MPH, K. Scott Baker, MD, MS, Debra L. Friedman, MD, MS, Kara Cushing-Haugen, MS, Mary E.D. Flowers, MD, Beth A Mueller, DrPH, Stephanie J. Lee, MD, MPH

Blood (2009) 114 (22): 517.

https://doi.org/10.1182/blood.V114.22.517.517

Published: 2009

Journal Articles

High Prevalence of Metabolic Syndrome Traits in Children with Acute Lymphoblastic Leukemia Entering Maintenance Therapy.

Adam J. Esbenshade, MD, Tatsuki Koyama, PhD, Jill H. Simmons, MD, James A. Whitlock, MD, Debra L. Friedman, MD, MS

Blood (2009) 114 (22): 4114.

https://doi.org/10.1182/blood.V114.22.4114.4114

Published: 2009

Journal Articles

Solid cancers after allogeneic hematopoietic cell transplantation

J. Douglas Rizzo, Rochelle E. Curtis, Gérard Socié, Kathleen A. Sobocinski, Ethel Gilbert, Ola Landgren, Lois B. Travis, William D. Travis, Mary E. D. Flowers, Debra L. Friedman, Mary M. Horowitz, John R. Wingard, H. Joachim Deeg

Blood (2009) 113 (5): 1175–1183.

https://doi.org/10.1182/blood-2008-05-158782

Published: 2009

Journal Articles

Prevalence of Metabolic Syndrome among Childhood Leukemia Survivors Treated with and without Hematopoietic Cell Transplantation

Eric J Chow, MD, MPH, Jean E Sanders, MD, Christian Roth, MD, Paul A Hoffmeister, MPH, Debra L Friedman, MD, MS

Blood (2008) 112 (11): 455.

https://doi.org/10.1182/blood.V112.11.455.455

Published: 2008

NARROW

Insurance, Financial Strain, Family Function, and Psychosocial Wellbeing in Pediatric Patients and Parents with Hematologic Malignancies

Performance of Positron Emission Tomography at Diagnosis and Response Assessment in Low and Intermediate-Risk Nodular Lymphocyte Predominant Hodgkin Lymphoma

A gene expression–based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma

The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity

Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group

Survival Varies By Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group

Pericardial effusion in Hodgkin lymphoma: a report from the Children’s Oncology Group AHOD0031 protocol

Survival By Race/Ethnicity in Children and Adolescents with Hodgkin Lymphoma Treated on Cooperative Group Trials in the U.S. and Canada: A Pooled Analysis of Children's Oncology Group Trials

Intermediate-Risk Lymphocyte-Predominant Hodgkin Lymphoma: AHOD0031: A Report from the Children's Oncology Group

Subsequent Malignant Neoplasms Among Children and Adolescents with Hodgkin Lymphoma Treated with Response-Adapted Therapy: A Report from the Children's Oncology Group Study AHOD0031

An Adjustable Markov Model to Project Life Expectancy (LE) for Early Stage Favorable Risk Hodgkin Lymphoma Patients Treated with Contemporary Therapy

Outcomes in Adolescents and Young Adults (AYA) with Hodgkin Lymphoma (HL) Treated on US Cooperative Group Protocols: An Adult Intergroup (E2496) and Children's Oncology Group (COG AHOD0031) Comparative Analysis

Prediction of Primary Treatment Outcome Using Gene Expression Profiling of Pre-Treatment Biopsies Obtained from Childhood and Adolescent Hodgkin Lymphoma Patients

18 f-FDG (FDG) PET Five-Point Visual and Quantitative SUV-Based Assessment and Prognosis in Pediatric Hodgkin Lymphoma (HL). A Preliminary Retrospective Analysis of Children's Oncology Group (COG) AHOD0031

The Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event Free Survival in Pediatric and Adolescent Hodgkin Lymphoma,

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

Population-Based Analysis of Late Cardiovascular Morbidity and Hospitalizations After Hematopoietic Cell Transplantation.

High Prevalence of Metabolic Syndrome Traits in Children with Acute Lymphoblastic Leukemia Entering Maintenance Therapy.

Solid cancers after allogeneic hematopoietic cell transplantation

Prevalence of Metabolic Syndrome among Childhood Leukemia Survivors Treated with and without Hematopoietic Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only